Insider · CIK 0001271857
Thomas P Schnettler
Files at FNA (Paragon 28, Inc.), AKYA (Akoya Biosciences, Inc.). First filing -, latest -.
In brief
Thomas P Schnettler files SEC Form 4 as director at FNA (Paragon 28, Inc.), and also at AKYA (Akoya Biosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Thomas P Schnettler has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 8, 2025 | AKYA Akoya Biosciences, Inc. | JOther Stock Option (Right to Buy)derivative | -16,860 | $0.00 | $0 | 0 | Jul 10, 2025 |
| Jul 8, 2025 | AKYA Akoya Biosciences, Inc. | JOther Stock Option (right to buy)derivative | -30,549 | $0.00 | $0 | 0 | Jul 10, 2025 |
| Jul 8, 2025 | AKYA Akoya Biosciences, Inc. | JOther Stock Option (right to buy)derivative | -56,322 | $0.00 | $0 | 0 | Jul 10, 2025 |
| Jul 8, 2025 | AKYA Akoya Biosciences, Inc. | JOther Stock Option (right to buy)derivative | -50,000 | $0.00 | $0 | 0 | Jul 10, 2025 |
| Apr 21, 2025 | FNA Paragon 28, Inc. | DDisposition to issuer Common Stock | -45,035 | - | - | 0 | Apr 21, 2025 |
Questions about Thomas P Schnettler
Answered from the filings on this page, as of the latest one.
Is Thomas P Schnettler buying or selling?
Thomas P Schnettler has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Thomas P Schnettler's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Thomas P Schnettler has 0.
Where does Thomas P Schnettler file Form 4?
Thomas P Schnettler has filed Form 4 at FNA (Paragon 28, Inc.); AKYA (Akoya Biosciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.